Point-of-care testing is associated with large reductions in the time to results for patients presenting with suspected COVID-19.
A comparative assessment of 5 immunoassays for SARS-CoV-2 showed that these assays achieved sensitivity and specificity of at least 98%.
In settings where acid-fast bacilli pulmonary diseases are suspected, gastric aspirate culture may be helpful for diagnosing Mycobacterium avium complex and M kansasii pulmonary disease.
The reissued EUA allows for fingerstick blood samples to be tested in point-of-care settings.
Researchers compared 3 immunochromatographic assays (Sienna™, Wondfo®, and Prometheus™) to detect antibodies against SARS-CoV-2 in serum samples, using RT-qPCR as a reference.
There is a low incidence of second PJI in patients with bacteremia or hematogenous periprosthetic joint infection with concomitant prosthetic implants.
Research results highlighted the need for continued supplemental NAATs for oropharyngeal samples being tested for Nisseria gonorrhoeae.
Results are provided within 15 minutes and can be read directly from the testing card.
Neutrophil-to-lymphocyte ratio may be a valuable biomarker to help clinicians recognize severe COVID-19 infection with moderate to severe ARDS.
Routine hepatitis C virus (HCV) testing at federally qualified health centers (FQHCs) would be cost-effective and could improve outcomes for people with HCV infections.
A novel tenofovir urine immunoassay demonstrated predictive utility and may adequately determine PrEP adherence.
By providing bundled HIV and HCV testing, substance use disorder treatment programs may create increased awareness of infection status among people with substance abuse disorders.
A team of researchers performed a systematic review to assess the methodologic quality of studies on the use of chest computed tomographic (CT) imaging in patients with COVID-19 and to determine the frequency of different chest CT findings.
Existing evidence on the diagnostic accuracy of serological tests for COVID-19 is characterized by high risks of bias and heterogeneity.
A study evaluated 5 commercially available assays that are approved for HIV seropositivity confirmation and could be readily performed in clinical laboratories.
A team of investigators from the Cleveland Clinic developed a prospective registry of all patients tested for COVID-19 in their health system that was used to validate a model to predict the risk of an individual having a positive COVID-19 test result.
HIV testing occurs at less than 1 percent of physician office and emergency department visits and at less than 3 percent of community health center (CHC) visits.
A team of investigators compared the sensitivity and specificity of 4 enzyme-linked immunosorbent assays and 2 rapid tests in patients with symptomatic SARS-CoV-2 infection.
A team of investigators reviewed data from institutions within the VA healthcare system to assess the ability of 2 algorithms to identify patients with intravenous drug use-associated infective endocarditis.
A team of French investigators sought to identify factors that could be considered predictive of the etiology of infectious encephalitis.